Unlike jabs, nasal vaccines target the respiratory tract, the body’s first line of defence against infection
- August 12, 2022
In a new study, Yale researchers show that moderate calorie restriction in people reduces the production of a protein called SPARC, which then reins in harmful inflammation and improves health in the aged. It could be a target for extending human health span, they report.
- August 12, 2022Source: The New York Times
While the risks of deaths and hospitalizations from Covid-19 are substantially lower now, navigating this phase of the pandemic can be frustrating and confusing.
- August 12, 2022
Yale researchers have unearthed a new clue that may explain who has long COVID—and how to treat the chronic conditionSource: Fortune
A new study released Wednesday shows one way doctors might diagnose who has the chronic condition and indicates a possible way to treat it.
- August 02, 2022
Yale researchers Akiko Iwasaki, PhD, and Harlan Krumholz, MD, are striving to solve the mysteries of long COVID, and to provide a compassionate voice for those feeling isolated and ignored by the medical community.
- July 27, 2022Source: Science
Immunobiologist Akiko Iwasaki joins White House summit to discuss the possibility of a nasal spray vaccine for COVID-19
- July 19, 2022Source: Time
"We need to educate, maintain, and improve T and B cell responses to prevent severe disease."
- July 05, 2022Source: CT Mirror
CDC analysis of Census data show 29.3% — nearly a third — of adult COVID survivors in Connecticut have experienced lingering symptoms.
- June 27, 2022
Dennis Shung, MD, MHS, PhD, and Benjamin Goldman-Israelow, MD, PhD, are celebrated as the 2022 Iva Dostanic, MD, PhD, Physician-Scientist Trainee Award honorees.
- June 16, 2022
Yale researchers have received a $12 million award from the NIH as part of the Human Immune Project Consortium to study vaccine responses in vulnerable groups, including patients with multiple sclerosis (MS) undergoing B cell depletion therapy, older adults including particularly vulnerable older residents of long-term care facilities, and certain individuals with sickle cell disease.